Lymphovenous Bypass for Skin Cancer

Recruiting in Palo Alto (17 mi)

Overseen byAshleigh M Francis, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: M.D. Anderson Cancer Center

No Placebo Group

Trial Summary

What is the purpose of this trial?To learn if LBP can help to prevent lymphedema when it is performed at the time of surgery rather than after a patient has already developed the disease.

Eligibility Criteria

This trial is for melanoma patients who are undergoing lymphadenectomy, a surgery to remove lymph nodes. It aims to see if performing Lymphovenous bypass (LVB) during the surgery can prevent lymphedema, which is swelling due to lymph fluid buildup.

Inclusion Criteria

I can understand and agree to the study's requirements.

I am willing to participate in the clinical trial.

I am 18 years old or older.

+1 more

Exclusion Criteria

Participants known to be pregnant at the time of surgery

My BMI is over 50.

I have taken blood thinners within a week before surgery.

Participant Groups

The study tests whether immediate Lymphovenous bypass (LVB) during lymph node removal can prevent the onset of lymphedema in skin cancer patients, compared with standard care where LVB isn't performed immediately.

2Treatment groups

Experimental Treatment

Group I: Upper extremity group recieving ALNDExperimental Treatment1 Intervention

Participants will be recruited pre-operatively by their treating physicians.

Group II: Lower extremity group getting ILNDExperimental Treatment1 Intervention

Participants will be recruited pre-operatively by their treating physicians.